Supplementary Figure 1 from Loss of Tuberous Sclerosis Complex 2 (TSC2) Is Frequent in Hepatocellular Carcinoma and Predicts Response to mTORC1 Inhibitor Everolimus

Autor: Alan Huang, Robert Schlegel, Andrew X. Zhu, Dalila Sellami, Benjamin H. Lee, Yan Wang, Michael R. Palmer, Marissa N. Balak, Adnan Derti, Manway Liu, David Ruddy, David Yang, Panisa Pochanard, Khee Chee Soo, Richard Ong, David Chen, Stephen L. Chan, Huai-Xiang Hao, Hung Huynh
Rok vydání: 2023
DOI: 10.1158/1535-7163.22501846
Popis: TSC2 loss in HCC cell lines leads to mTOR activation. (A) Reverse Phase Protein Array (RPPA) analysis of nine HCC cell lines for TSC2 protein levels and phosphorylation levels of S6K1, 4E-BP1, S6 and AKT. (B) Immunoblot of TSC2 wild-type HuH-7 cells treated with inhibitors of PI3K, AKT or MEK. (C) p-S6K1(T389) immunoblot of TSC2-null HCC cell lines treated with varying concentrations of everolimus.
Databáze: OpenAIRE